About Alwin Willcure Pharmaceuticals Private Limited
Data last updated:
Alwin Willcure Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2019PTC347077. Its GSTIN is 07AASCA0277C1ZR (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ravi Lalwani and Surjeet Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.N. 85 First Floor Right Portion Bharat Nagar Village, New Delhi, Delhi, India – 110044.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.52 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹9.44 Lakh (net margin 1.4%) and EBITDA of ₹26.07 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 26% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.13 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alwin.co.in.
Company details
Contact details
Alwin Willcure Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is alwin.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.N. 85 First Floor Right Portion Bharat Nagar Village, New Delhi, Delhi, India – 110044
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Alwin Willcure Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alwin Willcure Pharmaceuticals is trade. In detail, this covers wholesale trading and retail trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Alwin Willcure Pharmaceuticals Private Limited, buy the company report.
Financials of Alwin Willcure Pharmaceuticals Private Limited
FY 2024 filings availableAlwin Willcure Pharmaceuticals Private Limited reported revenue of ₹6.52 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 15% growth in the latest year. EBITDA rose 196% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.44 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alwin Willcure Pharmaceuticals Private Limited, buy the company report.
Board of directors of Alwin Willcure Pharmaceuticals Private Limited
Alwin Willcure Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Lalwani | Director | 11 Mar 2019 | 7 Years 7 Months | Current |
| Surjeet Kumar | Director | 11 Mar 2019 | 7 Years 7 Months | Current |
Peer comparison
Alwin Willcure Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Allen Biopharma Limited | ₹6.55 Cr (FY 2024) | 39.0% | Kolkata, West Bengal, India | |||
| Alwin Willcure Pharmaceuticals Private Limitedthis company | ₹6.52 Cr (FY 2025) | ₹9.44 Lakh | 1.4% | 15.0% | 3 | New Delhi, Delhi, India |
| Genesia Pharmaceuticals (India) Private Limited | ₹6.51 Cr (FY 2024) | 23.0% | Jaipur, Rajasthan, India | |||
| Grahams Pharmaceuticals Private Limited | ₹6.5 Cr (FY 2024) | -12.0% | Kochi, Kerala, India | |||
| Alleviare Life Sciences Private Limited | ₹6.49 Cr (FY 2025) | 2.0% | New Delhi, Delhi, India |
To see the full peer comparison of Alwin Willcure Pharmaceuticals Private Limited, buy the company report.
Auditor
Alwin Willcure Pharmaceuticals Private Limited is audited by MUKUL VERMA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUKUL VERMA & CO. | FY 2023 | 442071 |
Shareholding
The shareholding of Alwin Willcure Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Alwin Willcure Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jun 2024 | 100933242 | Others | ₹12.8 Lakh | Open | |
| 29 May 2024 | 100948661 | Others | ₹1 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Alwin Willcure Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alwin Willcure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Alwin Willcure Pharmaceuticals Private Limited has a workforce of 3 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Alwin Willcure Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AASCA0277C1ZR | Delhi | Active | 28 Jul 2019 |
| 23AASCA0277C1ZX | Madhya Pradesh | Active | 17 Sep 2019 |
To see the full GST registrations and return filing status of Alwin Willcure Pharmaceuticals Private Limited, buy the company report.
Recent activity
Alwin Willcure Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Ravi Lalwani was appointed as Director on 11 Mar 2019.
Frequently asked questions
Alwin Willcure Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 March 2019 (7+ years old) and is registered under CIN U24230DL2019PTC347077.
Alwin Willcure Pharmaceuticals has 2 current directors:
- Ravi Lalwani - Director
- Surjeet Kumar - Director
The latest financial statements of Alwin Willcure Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Alwin Willcure Pharmaceuticals is 07AASCA0277C1ZR, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 23AASCA0277C1ZX (Madhya Pradesh).
The CIN (Corporate Identification Number) of Alwin Willcure Pharmaceuticals is U24230DL2019PTC347077. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alwin Willcure Pharmaceuticals was incorporated on 11 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Alwin Willcure Pharmaceuticals by revenue are Allen Biopharma Limited, Genesia Pharmaceuticals (India) Private Limited, Grahams Pharmaceuticals Private Limited, Alleviare Life Sciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ravi Lalwani was appointed as Director on 11 Mar 2019. Surjeet Kumar was appointed as Director on 11 Mar 2019.
Alwin Willcure Pharmaceuticals can be reached through the website alwin.co.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Alwin Willcure Pharmaceuticals is at H.N. 85 First Floor Right Portion Bharat Nagar Village, New Delhi, Delhi, India – 110044.
Alwin Willcure Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.